Member Connect

Log in

Login to your account

Username
Password *
Remember Me

2017

Magis-Escurra C, Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Muylle I, Polcová V,Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBnet.
Treatment outcomes of MDR-TB and HIV co-infection in Europe.
Eur Respir J. 2017 Jun 8;49(6). pii: 1602363.
doi: 10.1183/13993003.02363-2016. Print 2017 Jun. PubMed PMID: 28596434.


Dedicoat MJ, Günther G, Crudu V, Duarte R, Gualano G, Magis-Escurra C, Rumetshofer R, Skrahina A, Spinu V, Tiberi S, Viiklepp P, van Leth F, Lange C; TBNET.
Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.
Am J Respir Crit Care Med. 2017 Mar 21.
doi: 10.1164/rccm.201612-2585LE. [Epub ahead of print] PubMed PMID: 28323453.


2016

Lange C, Günther G, van Leth F; TBNET.
More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.
N Engl J Med. 2016 Dec 29;375(26):2611.
doi:10.1056/NEJMc1613123. PubMed PMID: 28029919.


Bothamley GH, Ehlers C, Salonka I, Skrahina A, Orcau A, Codecasa LR, Ferrarese M, Pesut D, Solovic I, Dudnyk A, Anibarro L, Denkinger C, Guglielmetti L, Muylle I, Confalonieri M.
Pregnancy in patients with tuberculosis: a TBNET cross-sectional survey.
BMC Pregnancy Childbirth. 2016 Oct 12;16(1):304.
PubMed PMID: 27729022; PubMed Central PMCID: PMC5059923.

Abstract

BACKGROUND: Objectives: To determine whether the incidence of tuberculosis with pregnancy is more common than would be expected from the crude birth rate; to see whether there is significant delay in the diagnosis of tuberculosis during pregnancy.
METHOD: Design: A cross-sectional survey.
SETTING: 13 tuberculosis clinics within different European countries and the USA.
POPULATION/SAMPLE: All patients with tuberculosis seen at these clinics for a period > 1 year.
INSTRUMENT: Questionnaire survey based on continuous data collection.
MAIN OUTCOME MEASURES: number and proportion of women with tuberculosis who were pregnant; timing of diagnosis in relation to pregnancy, including those who were pregnant or delivered in the 3 months prior to the diagnosis of TB and those who developed TB within 3 months after delivery.
RESULTS: Pregnancy occurred in 224 (1.5 %) of 15,217 TB patients and followed the expected rate predicted from the crude birth rate for the clinic populations. TB was diagnosed more commonly in the 3 months after delivery (n = 103) than during pregnancy (n = 68; χ (2) = 25.1, P < 0.001).
CONCLUSIONS: TB is diagnosed more frequently after delivery, despite variations in local TB incidence and healthcare systems.


Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBNET.
Treatment Outcomes in Multidrug-Resistant Tuberculosis.
N Engl J Med. 2016 Sep 15;375(11):1103-5.
doi: 10.1056/NEJMc1603274. PubMed PMID: 27626539.


Blauenfeldt T, Wagner D, Aabye M, Heyckendorf J, Lange B, Lange C, Ernst M, Ravn P, Duarte R, Morais C, Hoffmann M, Schoch OD, Dominguez J, Latorre I, Ruhwald M.
Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study.
Tuberculosis (Edinb). 2016 May;98:7-12.
doi: 10.1016/j.tube.2015.04.013. Epub 2015 May 15. PubMed PMID: 27156612.

Abstract

INTRODUCTION: Interferon-γ (IFN-γ) inducible protein 10kD (IP-10) and IFN-γ release assays (IGRAs) are immunodiagnostic tests aiming to identify the presence of specific cellular immune responses, interpreted as markers for latent infection with Mycobacterium tuberculosis. Incubation at higher temperatures could affect IFN-γ and IP-10 responsiveness in order to improve the performance of IP-10 release assays and IGRAs.
AIM: The aim of this study was to assess the robustness of whole blood based IP-10 release assay and IGRAs and the effect of hyper-thermic incubation (39 °C) on the diagnostic accuracy of IP-10 release assay and IGRAs.
RESULTS: We included 65 patients with confirmed pulmonary tuberculosis and 160 healthy controls from 6 European centres collaborating in the TBnet. In patients, IP-10 responses increased 1.07 (IQR 0.90-1.36) fold and IFN-γ responses decreased 0.88 (IQR 0.57-1.02) fold, with 39 °C compared to 37 °C incubation temperature. At 37 °C IGRA sensitivity was 85% and IP-10 sensitivity was 82%, whereas specificity was 97% for both tests (p > 0.8). These minor changes observed as a result of hyper-thermic incubation were not sufficient to impact IGRA and IP-10 release assay test performance.
CONCLUSION: The performance of IGRA and IP-10 release assays is robust despite variations in the incubation temperature between 37 °C and 39 °C.


Lange C, van Leth F, Sester M; TBnet.
Viral Load and Risk of Tuberculosis in HIV Infection.
J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):e51-3.
doi: 10.1097/QAI.0000000000000834. PubMed PMID: 26761521.


Domínguez J, Boettger EC, Cirillo D, Cobelens F,Eisenach KD, Gagneux S, Hillemann D, Horsburgh R, Molina-Moya B, Niemann S, Tortoli E,Whitelaw A, Lange C for the TBNET and RESIST-TB networks.
Clinical implications of molecular drug resistance testing for M. tuberculosis: a TBNET/RESIST-TB consensus statement
Int J Tuberc Lung Dis. 2016 Jan;20(1):24-42.
doi: 10.5588/ijtld.15.0221.


2015

Dierig A, Tebruegge M, Krivec U, Heininger U, Ritz N; Paediatric Tuberculosis  Network European Trials group (ptbnet).
Current status of Bacille Calmette Guérin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines. 
Vaccine. 2015 Sep 11;33(38):4994-9.
doi: 10.1016/j.vaccine.2015.06.097. Epub 2015 Jul 4. PubMed PMID: 26151543. Pubmed


Günther G, Gomez GB, Lange C, Rupert S, van Leth F; on behalf of the TBNET. 
Availability, price and affordability of anti-tuberculosis drugs in Europe: A TBNET survey.
Eur Respir J.2014 Nov 13. pii: erj01246-2014. [Epub ahead of print]
Pubmed


Ritz N, Brinkmann F, Garcia BS, Tebruegge M, Kampmann B; Paediatric Tuberculosis Network European Trials group (ptbnet).
Tuberculosis in young refugees.
Lancet. 2015 Dec 19;386(10012):2475-6.
doi: 10.1016/S0140-6736(15)01241-6. Epub 2015 Dec 18. PubMed PMID: 26738710.  Pubmed


Sester M, van Crevel R, Leth Fv, Lange C.
Numbers needed to treat to prevent tuberculosis.
Eur Respir J. 2015 Dec;46(6):1836-8.
doi: 10.1183/13993003.01047-2015. PubMed PMID: 26621887. Pubmed


Zellweger JP, Sotgiu G, Block M, Dore S, Altet N, Blunschi R, Bogyi M, Bothamley G, Bothe C, Codecasa L, Costa P, Dominguez J, Duarte R, Fløe A, Fresard I, García-García JM, Goletti D, Halm P, Hellwig D, Henninger E, Heykes-Uden H, Horn L, Kruczak K, Latorre I, Pache G, Rath H, Ringshausen FC, Ruiz AS, Solovic I, Souza-Galvão ML, Widmer U, Witte P, Lange C; TBNET.
Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.
Am J Respir Crit Care Med. 2015 May 15;191(10):1176-84.
doi: 10.1164/rccm.201502-0232OC. PubMed PMID: 25763458. Pubmed


2014

Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Gorek Dilektasli A, Domínguez J, Duarte R, Ernst M, Oner Eyuboglu F, Gerogianni I, Girardi E, Goletti D, Janssens JP, Julander I, Lange B, Latorre I, Losi M, Markova R, Matteelli A, Milburn H, Ravn P, Scholman T, Soccal PM, Straub M, Wagner D, Wolf T, Yalcin A, Lange C; for the TBNET. 
Risk Assessment of Tuberculosis in Immunocompromised Patients - A TBNET Study,
Am J Respir Crit Care Med. 2014 Oct 10. [Epub ahead of print],
PMID: 25303140 [PubMed - as supplied by publisher]  Pubmed


Christoph Lange, Ibrahim Abubakar, Jan-Willem C. Alffenaar, Graham Bothamley, Jose A. Caminero, Anna Cristina C. Carvalho, Kwok-Chiu Chang, Luigi Codecasa, Ana Correia, Valeriu Crudu, Peter Davies, Martin Dedicoat, Francis Drobniewski, Raquel Duarte, Cordula Ehlers, Connie Erkens, Delia Goletti, Gunar Günther, Elmira Ibraim, Beate Kampmann, Liga Kuksa, Wiel de Lange, Frank van Leth, Jan van Lunzen, Alberto Matteelli, Dick Menzies, Ignacio Monedero, Elvira Richter, Sabine Ru¨sch-Gerdes, Andreas Sandgren, Anna Scardigli, Alena Skrahina, Enrico Tortoli, Grigory Volchenkov, Dirk Wagner, Marieke J. van der Werf, Bhanu Williams, Wing-Wai Yew, Jean-Pierre Zellweger and Daniela Maria Cirillo for the TBNET; 
Management of patients with multidrugresistant/ 
extensively drug-resistant tuberculosis in Europe: a TBNET 
consensus statement,
ERJ 2014
Pubmed ERJ

2013

Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, Beylis N, Boeree MJ, Cacho J, Chihota V, Chimara E, Churchyard G, Cias R, Dasa R, Daley CL, Dekhuijzen PN, Domingo D, Drobniewski F, Esteban J, Fauville-Dufaux M, Folkvardsen DB, Gibbons N, Gómez-Mampaso E, Gonzalez R, Hoffmann H, Hsueh PR, Indra A, Jagielski T, Jamieson F, Jankovic M, Jong E, Keane J, Koh WJ, Lange B, Leao S, Macedo R, Mannsåker T, Marras TK, Maugein J, Milburn HJ, Mlinkó T, Morcillo N, Morimoto K, Papaventsis D, Palenque E, Paez-Peña M, Piersimoni C, Polanová M, Rastogi N, Richter E, Ruiz-Serrano MJ, Silva A, da Silva MP, Simsek H, van Soolingen D, Szabó N, Thomson R, Fernandez MT, Tortoli E, Totten SE, Tyrrell G, Vasankari T, Villar M, Walkiewicz R, Winthrop K, Wagner D; for NTM-NET (www.ntm-net.org).
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: A NTM-NET collaborative study.
ERJ 2013

  Pubmed

Tebruegge M, Salo E, Ritz N, Kampmann B, On Behalf Of The Paediatric Tuberculosis Network European Trialsgroup ptbnet.
Inclusion of latent tuberculosis infection as a separate entity into the international classification of diseases. 
Thorax. 2013 Jun; 68(6):588.
doi: 10.1136/thoraxjnl-2012-202824


  Pubmed

2012

Giovanni Sotgiu, Lia D’Ambrosio, Rosella Centis, Graham Bothamley, Daniela M. Cirillo, Saverio De Lorenzo, Gunar Guenther, Kai Kliiman, Ralf Muetterlein, Victor Spinu, Miguel Villar, Jean-Pierre Zellweger, Andreas Sandgren, Emma Huitric, Christoph Lange, Davide Manissero and Giovanni Battista Migliori. Availability of anti-tuberculosis drugs in Europe. Eur Respir J. 2012


  Pubmed
ERJ

Rasu Roy R, Sotgui G, Altet-Gomez N, Tsolia M, Ruga E, Velizarova S, Kampmann B. Identifying predictors of interferon-gamma release assay results in pediatric latent tuberculosis: a protective role of BCG? A PTBNET collaborative study. Am J Respir Crit Care Med 2012


  Pubmed
Am J Respr Crit Care Med

Bumbacea D, Arend SM, Eyuboglu F, Fishman JA; GolettiD, Ison MG, Jones CE, Kampmann B, Kotton CN, Lange C, Ljungman P; Milburn H; Morris MI; Muller E; Muñoz P, Nellore A, Rieder HL, Sester U, Theodoropoulos N, Wagner D, Sester M. The risk of tuberculosis in transplant candidates and recipients: A TBNET consensus statement. Eur Respir J. 2012


Giehl C, Lange C, Duarte R, Bothamley G, Gerlach C, Cirillo DM, Wagner D, Kampmann B, Goletti D, Juers T, Sester M., TBNET - Collaborative research on tuberculosis in Europe, Eur J Microbiol Immunol (Bp). 2012 Dec;2(4):264-74. doi: 10.1556/EuJMI.2.2012.4.4. Epub 2012 Dec 11.


 

Pubmed

 

 

Pubmed

Migliori GB, Sotgiu G, D’Ambrosio L, Centis R, Lange C, Bothamley G, Cirillo DM, De Lorenzo S, Guenther G, Kliiman K, Muetterlein R, Spinu V, Villar M, Zellweger JP, Sandgren A, Huitric E, Manissero D. TB and MDR/XDR-TB in the EU and EEA/EFTA countries: managed or mismanaged? Eur Respir J. 2012


  Pubmed

2011

Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger JP, Huitric E, Sandgren A, Manissero D. Interferon-g release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011;37(1):88-99.


  Pubmed
ERJ

Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, Bossink A, Dheda K, Diel R, Dominguez J, Lipman M, Nemeth J, Ravn P, Winkler S, Huitric E, Sandgren A, Manissero D. Interferon-g release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2011; 37(1):100-11.


  Pubmed
ERJ

Lange C, Sester M, Sotgiu G, Giehl C, Girardi E, Bossink A, Dheda K, Diel R, Dominguez J, Lipman M, Migliori GB, Nemeth J, Ravn P, Winkler S, Huitric E, Sandgren A, Manissero D. Interferon- release assays for diagnosis of active pleural tuberculosis: a developing world perspective. Eur. Respir. J. 2011 38: 747-748.


  Pubmed
ERJ

Lange C, Rieder H, Sester M, Milburn H, Kampmann B, Migliori GB, Solovic I. Diagnosis of tuberculosis in patients with psoriasis: the need for a modified approach. Eur. Respir. J. 2011 38: 232-233.


  Pubmed
ERJ

Ruhwald M, Dominguez J, Latorre I, Losi M, Richeldi L, Pasticci MB, Mazzolla R, Goletti D, Butera O, Bruchfeld J, Gaines H, Gerogianni I, Tuuminen T, Ferrara G, Eugen-Olsen J, Ravn P; TBNET. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb). 2011; 91(3):260-7


 

Pubmed
Link

Sotgiu G, D'AmbrosioL, Centis R, Bothamley G, Cirillo DM, De Lorenzo S, Guenther G, Kliiman K, Muetterlein R, Spinu V, Villar M, Zellweger JP, Sandgren A, Huitric E, Lange C, Manissero D, Migliori GB.  TB and M/XDRTB infection control in European TB centres:  the Achilles’ heel?   Eur Respir J. 2011 Nov; 38(5):1221-3. doi: 10.1183/09031936.00029311.


  Pubmed

Migliori GB, Sotgiu G, Lange C, Centis R.  Extensively drug-resistant tuberculosis: back to the future.  Eur Respir J. 2010 Sep; 36(3):475-7. doi: 10.1183/09031936.00025910.


  Pubmed

2010

 

Solovic I, Sester M, Gomez-Reino JJ, Rieder HL, Ehlers S, Milburn HJ, Kampmann B, Hellmich B, Groves R, Schreiber S, Wallis RS, Sotgiu G, Schövinck EH, Goletti D, Zellweger JP, Diel R, Carmona L, Bartalesi F, Ravn P, Bossink A, Duarte R, Erkens C, Clark J, Migliori GB, Lange C. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J. 2010;36(5):1185-206.


  Pubmed
ERJ

Sotgiu G, Centis R, D'ambrosio L, De Lorenzo S, D'arcy Richardson M, Lange C, Manissero D, Migliori GB; TBNET MDR-TB project. Development of a standardised tool to survey MDR-/XDR-TB case management in Europe. Eur Respir J. 2010; 36(1):208-11.


  Pubmed
ERJ

Sotgiu G, Centis R, Lange C, D'Ambrosio L, Guenther G, Spanevello A, Migliori GB. Safety of linezolid in MDR-/XDR-TB treatment: is there any difference in India and Europe?. Eur. Respir. J. 2010 35: 938-940.


  Pubmed
ERJ

Lange C, Bossink A, Eberhardt R, Goletti D, Jafari C, Latorre I, Kirsten D, Losi M, Migliori GB, Sotgiu G. Bronchoalveolar lavage immunodiagnosis for tuberculosis suspects in Europe and Africa. Thorax. 2010 Sep;65(9):842; author reply 842-3.


  Pubmed
Link

Erkens CG, Kamphorst M, Abubakar I, Bothamley GH, Chemtob D, Haas W, Migliori GB, Rieder HL, Zellweger JP, Lange C. Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J. 2010; 36(4):925-49


  Pubmed
ERJ

2009

Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, Bossink A, Magdorf K, Hölscher C, Kampmann B, Arend SM, Detjen A, Bothamley G, Zellweger JP, Milburn H, Diel R, Ravn P, Cobelens F, Cardona PJ, Kan B, Solovic I, Duarte R, Cirillo DM; C. Lange; TBNET. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J. 2009; 33(5):956-73.


  Pubmed ERJ

Bamford AR, Crook AM, Clark JE, Nademi Z, Dixon G, Paton JY, Riddell A, Drobniewski F, Riordan A, Anderson ST, Williams A, Walters S, Kampmann B. Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. Arch Dis Child. 2010;95(3):180-6.


  Pubmed
 
ADC

Migliori GB, D'Arcy Richardson M, Sotgiu G, Lange C. Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control. Clin Chest Med. 2009;30:637-65


  Pubmed Link

Jafari C, Thijsen S, Sotgiu G, Goletti D, Domínguez Benítez JA, Losi M, Eberhardt R, Kirsten D, Kalsdorf B, Bossink A, Latorre I, Migliori GB, Strassburg A, Winteroll S, Greinert U, Richeldi L, Ernst M, Lange C; Tuberculosis Network European Trialsgroup. Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study. Am J Respir Crit Care Med. 2009;180(7):666-73.


  Pubmed AJRCCM

Migliori GB, Eker B, Richardson MD, Sotgiu G, Zellweger JP, Skrahina A, Ortmann J, Girardi E, Hoffmann H, Besozzi G, Bevilacqua N, Kirsten D, Centis R, Lange C; TBNET Study Group. A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis. Eur Respir J. 2009; 34(2):387-93.


  Pubmed ERJ
 

Sotgiu G, Ferrara G, Matteelli A, Richardson MD, Centis R, Ruesch-Gerdes S, Toungoussova O, Zellweger JP, Spanevello A, Cirillo D, Lange C, Migliori GB. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J. 2009; 33(4):871-81.


  Pubmed ERJ
 

Migliori GB, Sotgiu G, D'Arcy Richardson M, Centis R, Facchini A, Guenther G, Spanevello A, Lange C; TBNET. MDR-TB and XDR-TB: drug resistance and treatment outcomes. Eur Respir J. 2009; 34(3):778-9


  Pubmed ERJ
 

Sotgiu G, Lange C, Richardson MD, Matteelli A, Centis R, Eker B, Guenther G, Spanevello A, Migliori GB; TBNET. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. J Antimicrob Chemother. 2009;64(4):879-83.


  Pubmed
 
JAC
 

Migliori GB, Sotgiu G, D'Arcy Richardson M, Centis R, Guenther G, Hoffmann H, Cirillo DM, Toungossova O, Kliiman K, De Lorenzo S, Spanevello A, Lange C; Tuberculosis Network European Trialsgroup. Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment. Clin Infect Dis. 2009 15;49(2):315-6


  Pubmed CID
 

2008

Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K, Ortmann J, Matteelli A, Spanevello A, Cirillo DM; SMIRA/TBNET Study Group. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results. Clin Infect Dis. 2008 15;46(6):958-9.


  Pubmed CID
 

Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K, Codecasa LR, Spanevello A, Cirillo DM; SMIRA/TBNET Study Group. Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis? Eur Respir J. 2008;31(4):904-5.


  Pubmed ERJ
 

Migliori GB, Lange C, Centis R, Sotgiu G, Mütterlein R, Hoffmann H, Kliiman K, De Iaco G, Lauria FN, Richardson MD, Spanevello A, Cirillo DM; TBNET Study Group. Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. Eur Respir J. 2008; 31(6):1155-9.


  Pubmed ERJ

 

Bothamley GH, Ditiu L, Migliori GB, Lange C; TBNET contributors. Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey. Eur Respir J. 2008; 32(4):1023-30.


  Pubmed ERJ
 

Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, Eugen-Olsen J, Ravn P; TBNET. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J. 2008; 32(6):1607-15.


  Pubmed ERJ
 

Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C; German TBNET Group. Multidrug-and extensively drug-resistant tuberculosis, Germany. Emerg Infect Dis. 2008; 14(11):1700-6.


  Pubmed EID
 

Goletti D, Carrara S, Butera O, Amicosante M, Ernst M, Sauzullo I, Vullo V, Cirillo D, Borroni E, Markova R, Drenska R, Dominguez J, Latorre I, Angeletti C, Navarra A, Petrosillo N, Lauria FN, Ippolito G, Migliori GB, Lange C, Girardi E. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. PLoS One. 2008; 3(10):e3417.


  Pubmed PLoSONE
 

2007

Losi M, Bossink A, Codecasa L, Jafari C, Ernst M, Thijsen S, Cirillo D, Ferrarese M, Greinert U, Fabbri LM, Richeldi L, Lange C; European Tuberculosis Network TBNET. Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy. Eur Respir J. 2007;30(6):1173-9.


  Pubmed ERJ

 

Migliori GB, Ortmann J, Girardi E, Besozzi G, Lange C, Cirillo DM, Ferrarese M, De Iaco G, Gori A, Raviglione MC; SMIRA/TBNET Study Group. Extensively drug-resistant tuberculosis, Italy and Germany. Emerg Infect Dis. 2007;13(5):780-2.


  Pubmed EID
 
Migliori GB, Besozzi G, Girardi E, Kliiman K, Lange C, Toungoussova OS, Ferrara G, Cirillo DM, Gori A, Matteelli A, Spanevello A, Codecasa LR, Raviglione MC; SMIRA/TBNET Study Group. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J. 2007; 30(4):623-6.   Pubmed ERJ